R John Moore

Affiliations

  • General Counsel at Edgewise Therapeutics Inc. (EWTX), 2025-05-08
  • Vp, General Counsel at Array Biopharma Inc (ARRY), 2017-04-07
  • Director at Nivalis Therapeutics Inc. (NVLS), 2016-09-14
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EWTX $16.45 1,930 $31,756.61 6,531 2025-05-02 Filing
EWTX $27.63 20,922 $578,064.40 3,252 2024-09-23 Filing
EWTX $28.37 50,000 $1,418,510.00 3,252 2024-09-20 Filing
EWTX $18.91 1,956 $36,987.96 3,252 2024-05-02 Filing
EWTX $20.01 8,029 $160,657.08 0 2024-02-09 Filing